These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9146043)

  • 1. [Unfavorable effects of transfusion at the Japanese Red Cross Central Blood Center].
    Juji T
    Rinsho Ketsueki; 1997 Apr; 38(4):245-8. PubMed ID: 9146043
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transfusion: risks and future prospects].
    Molaro GL
    G Clin Med; 1990 Oct; 71(10):547-59. PubMed ID: 2289650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adverse effects and infections caused by platelet concentrate].
    Tadokoro K
    Rinsho Ketsueki; 2000 Jun; 41(6):468-71. PubMed ID: 10921343
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of blood products--the status and appropriate application of blood transfusion].
    Kamihira S
    Nihon Rinsho; 1991 Dec; 49 Suppl():799-804. PubMed ID: 1808352
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan.
    Juji T; Takahashi K; Shibata Y; Ide H; Sakakibara T; Ino T; Mori S
    N Engl J Med; 1989 Jul; 321(1):56. PubMed ID: 2733750
    [No Abstract]   [Full Text] [Related]  

  • 6. An update on post-transfusion hepatitis in Italy.
    Ciccozzi M; Stroffolini T; Tosti ME; Marzolini A; Mele A
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):665. PubMed ID: 10076795
    [No Abstract]   [Full Text] [Related]  

  • 7. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential usefulness of photochemotherapy using 8-methoxypsoralen in the treatment of posttransfusion graft-versus-host disease.
    Nishimura M; Akaza T; Tadokoro K; Juji T
    Vox Sang; 1998; 75(4):306-7. PubMed ID: 9873267
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risk of transfusion-transmitted infection in Japan].
    Satake M
    Rinsho Ketsueki; 2014 Oct; 55(10):2152-61. PubMed ID: 25297782
    [No Abstract]   [Full Text] [Related]  

  • 10. Transfusion-associated hepatitis in children with hematologic malignancies in Northern India.
    Arora B; Joshi YK; Salhan RN; Arya LS; Prakash S
    Med Pediatr Oncol; 2003 Aug; 41(2):166-8. PubMed ID: 12825229
    [No Abstract]   [Full Text] [Related]  

  • 11. Risks of blood transfusion and their prevention.
    Sandler SG; Yu H; Rassai N
    Clin Adv Hematol Oncol; 2003 May; 1(5):307-13. PubMed ID: 16224428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infections as complications of blood transfusion]].
    Kłos M
    Przegl Epidemiol; 2001; 55 Suppl 3():4-9. PubMed ID: 11984956
    [No Abstract]   [Full Text] [Related]  

  • 13. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-transmitted viruses.
    Wright-Kanuth MS; Smith LA
    Clin Lab Sci; 2003; 16(4):221-9. PubMed ID: 14626440
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood transmitted illnesses.
    Weise W
    Haematologia (Budap); 1983; 16(1-4):135-9. PubMed ID: 6434378
    [No Abstract]   [Full Text] [Related]  

  • 16. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion associated graft versus host disease (TA-GVHD)].
    Takahashi K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):605-8. PubMed ID: 9851229
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-associated graft-versus-host disease: a perspective from a cell therapy laboratory.
    Hummon D; Zantek ND; Sumstad D; Miller JS; McKenna DH
    Transfusion; 2009 May; 49(5):1018-9. PubMed ID: 19426202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.